RIP1 inhibition protects retinal ganglion cells in glaucoma models of ocular injury
Open Access
- 24 October 2024
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 32 (2) , 353-368
Abstract
Receptor-interacting protein 1 (RIP1, RIPK1) is a critical mediator of multiple signaling pathways that promote inflammatory responses and cell death. The kinase activity of RIP1 contributes to the pathogenesis of a number of inflammatory and neurodegenerative diseases. However, the role of RIP1 in retinopathies remains unclear. This study demonstrates that RIP1 inhibition protects retinal ganglion cells (RGCs) in preclinical glaucoma models. Genetic inactivation of RIP1 improves RGC survival and preserves retinal function in the preclinical glaucoma models of optic nerve crush (ONC) and ischemia–reperfusion injury (IRI). In addition, the involvement of necroptosis in ONC and IRI glaucoma models was examined by utilizing RIP1 kinase-dead (RIP1-KD), RIP3 knockout (RIP3-KO), and MLKL knockout (MLKL-KO) mice. The number of RGCs, retinal thickness, and visual acuity were rescued in RIP1-kinase-dead (RIP1-KD) mice in both models, while wild-type (WT) mice experienced significant retinal thinning, RGC loss, and vision impairment. RIP3-KO and MLKL-KO mice showed moderate protective effects in the IRI model and limited in the ONC model. Furthermore, we confirmed that a glaucoma causative mutation in optineurin, OPTN-E50K, sensitizes cells to RIP1-mediated inflammatory cell death. RIP1 inhibition reduces RGC death and axonal degeneration following IRI in mice expressing OPTN-WT and OPTN-E50K variant mice. We demonstrate that RIP1 inactivation suppressed microglial infiltration in the RGC layer following glaucomatous damage. Finally, this study highlights that human glaucomatous retinas exhibit elevated levels of TNF and RIP3 mRNA and microglia infiltration, thus demonstrating the role of neuroinflammation in glaucoma pathogenesis. Altogether, these data indicate that RIP1 plays an important role in modulating neuroinflammation and that inhibiting RIP1 activity may provide a neuroprotective therapy for glaucoma.Keywords
This publication has 83 references indexed in Scilit:
- TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in AgingCell, 2018
- Ischemia/Reperfusion Injury and its Consequences on Immunity and InflammationCurrent Transplantation Reports, 2014
- A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis DevelopmentCell Reports, 2013
- Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia–reperfusion in vivoBasic Research in Cardiology, 2012
- FK506 blocks activation of the intrinsic caspase cascade after optic nerve crushExperimental Eye Research, 2005
- Role of tumor necrosis factor receptor-1 in the death of retinal ganglion cells following optic nerve crush injury in miceBrain Research, 2004
- Tumor necrosis factor-?: A potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve headGlia, 2000
- Matrix Metalloproteinases and Tumor Necrosis Factor α in Glaucomatous Optic Nerve HeadArchives of Ophthalmology (1950), 2000
- Relationship Between Intraocular Pressure and Primary Open Angle Glaucoma Among White and Black AmericansArchives of Ophthalmology (1950), 1991
- Untreated Ocular HypertensionArchives of Ophthalmology (1950), 1977